Diabetes is a chronic, life-threatening disease which affects more than 16 million Americans and more than 100 million people worldwide. And it is growing even more prevalent as the population ages. Treatment is available but inadequate and requires intense commitment to do properly; even so, the disease is not curable and many diabetics ultimately experience long-term complications such as renal failure, blindness, and nephropathy. In recent years, studies such as the Diabetes Control and Complications Trial (DCCT) have statistically demonstrated that the long-term complication rate of diabetes could be substantially reduced with intensive, careful therapy.
The opportunity hasn't been lost on health care manufacturers, many of which have tried their hand at developing new methods of treating and monitoring the disease. Dozens of start-ups have...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?